Cite
Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication.
MLA
Soliman, Dina Sameh, et al. “Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication.” Journal of Medical Cases, vol. 13, no. 1, Jan. 2022, pp. 1–4. EBSCOhost, https://doi.org/10.14740/jmc3827.
APA
Soliman, D. S., Al Battah, A., Al Faridi, D., & Ibrahim, F. (2022). Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication. Journal of Medical Cases, 13(1), 1–4. https://doi.org/10.14740/jmc3827
Chicago
Soliman, Dina Sameh, Afaf Al Battah, Dekra Al Faridi, and Feryal Ibrahim. 2022. “Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication.” Journal of Medical Cases 13 (1): 1–4. doi:10.14740/jmc3827.